21 related articles for article (PubMed ID: 7635426)
1. Role of Vitamin C in Skin Diseases.
Wang K; Jiang H; Li W; Qiang M; Dong T; Li H
Front Physiol; 2018; 9():819. PubMed ID: 30022952
[TBL] [Abstract][Full Text] [Related]
2. Porphyria cutanea tarda: multiplicity of risk factors including HFE mutations, hepatitis C, and inherited uroporphyrinogen decarboxylase deficiency.
Egger NG; Goeger DE; Payne DA; Miskovsky EP; Weinman SA; Anderson KE
Dig Dis Sci; 2002 Feb; 47(2):419-26. PubMed ID: 11855561
[TBL] [Abstract][Full Text] [Related]
3. Uroporphyria produced in mice by iron and 5-aminolaevulinic acid does not occur in Cyp1a2(-/-) null mutant mice.
Sinclair PR; Gorman N; Dalton T; Walton HS; Bement WJ; Sinclair JF; Smith AG; Nebert DW
Biochem J; 1998 Feb; 330 ( Pt 1)(Pt 1):149-53. PubMed ID: 9461503
[TBL] [Abstract][Full Text] [Related]
4. Ascorbic acid inhibition of cytochrome P450-catalyzed uroporphyrin accumulation.
Sinclair PR; Gorman N; Walton HS; Bement WJ; Jacobs JM; Sinclair JF
Arch Biochem Biophys; 1993 Aug; 304(2):464-70. PubMed ID: 8346921
[TBL] [Abstract][Full Text] [Related]
5. Absolute requirement for iron in the development of chemically induced uroporphyria in mice treated with 3-methylcholanthrene and 5-aminolevulinate.
Nakano K; Ishizuka M; Sakamoto KQ; Fujita S
Biometals; 2009 Apr; 22(2):345-51. PubMed ID: 18956144
[TBL] [Abstract][Full Text] [Related]
6. CYP1A2 is essential in murine uroporphyria caused by hexachlorobenzene and iron.
Sinclair PR; Gorman N; Walton HS; Bement WJ; Dalton TP; Sinclair JF; Smith AG; Nebert DW
Toxicol Appl Pharmacol; 2000 Jan; 162(1):60-7. PubMed ID: 10631128
[TBL] [Abstract][Full Text] [Related]
7. Effect of iron and ascorbate on uroporphyria in ascorbate-requiring mice as a model for porphyria cutanea tarda.
Gorman N; Zaharia A; Trask HS; Szakacs JG; Jacobs NJ; Jacobs JM; Balestra D; Sinclair JF; Sinclair PR
Hepatology; 2007 Jan; 45(1):187-94. PubMed ID: 17187429
[TBL] [Abstract][Full Text] [Related]
8. Identification of CYP1A5 as the CYP1A enzyme mainly responsible for uroporphyrinogen oxidation induced by AH receptor ligands in chicken liver and kidney.
Sinclair PR; Gorman N; Walton HS; Sinclair JF; Lee CA; Rifkind AB
Drug Metab Dispos; 1997 Jul; 25(7):779-83. PubMed ID: 9224771
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome P450 and its interactions with the heme biosynthetic pathway.
De Matteis F; Marks GS
Can J Physiol Pharmacol; 1996 Jan; 74(1):1-8. PubMed ID: 8963944
[TBL] [Abstract][Full Text] [Related]
10. A rational approach for improving the ascorbate antineoplastic activity.
Bocci V; Zanardi I; Travagli V
Cancer Invest; 2014 Mar; 32(3):81-4. PubMed ID: 24499108
[No Abstract] [Full Text] [Related]
11. Ascorbic acid inhibits chemically induced uroporphyria in ascorbate-requiring rats.
Sinclair PR; Gorman N; Sinclair JF; Walton HS; Bement WJ; Lambrecht RW
Hepatology; 1995 Aug; 22(2):565-72. PubMed ID: 7635426
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
